FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

430306004: certolizumab pegol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2708529014 Certolizumab pegol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2764885014 Certolizumab pegol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
367461000077114 certolizumab pegol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
654521000077112 certolizumab pegol (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
799481000172116 certolizumab pégol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Certolizumab pegol (substance) Has disposition (attribute) Tumor necrosis factor alpha inhibitor (disposition) true Inferred relationship Some
Certolizumab pegol (substance) est un(e) (attribut) agent anti-tumor necrosis factor alpha true Inferred relationship Some
Certolizumab pegol (substance) est un(e) (attribut) Inflammatory bowel disease agent (substance) false Inferred relationship Some
Certolizumab pegol (substance) est un(e) (attribut) Monoclonal antibody agent (substance) false Inferred relationship Some
Certolizumab pegol (substance) est un(e) (attribut) Monoclonal antibody (substance) true Inferred relationship Some
Certolizumab pegol (substance) est un(e) (attribut) Gastrointestinal agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only certolizumab pegol (medicinal product) a pour principe actif (attribut) True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing certolizumab pegol in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Certolizumab pegol (substance) Inferred relationship Some 1
Certolizumab pegol only product in parenteral dose form a pour principe actif (attribut) True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Certolizumab pegol (substance) Inferred relationship Some 1
certolizumab pégol a pour principe actif (attribut) True Certolizumab pegol (substance) Inferred relationship Some 1
Certolizumab pegol 200mg powder for injection solution vial + diluent (product) a pour principe actif (attribut) False Certolizumab pegol (substance) Inferred relationship Some
Certolizumab pegol therapy (procedure) substance utilisée (attribut) True Certolizumab pegol (substance) Inferred relationship Some 2
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) a pour principe actif (attribut) False Certolizumab pegol (substance) Inferred relationship Some

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set

GB English

US English

Back to Start